Ashlea Campbell

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Infectious Diseases

Mesenchymal Stem Cells

Clinical Practice

Top Venues

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal 54 (2) (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal 54 (2) (2023)